Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$41.17 -0.33 (-0.80%)
2/9/2010 4:05 PM

Inverness Medical Innovations, Inc. (IMA)

CAPS Rating:
***

The Company is a global developer, manufacturer and marketer of vitro diagnostic products for the over-the-counter pregnancy and fertility/ovulation test market and the professional rapid diagnostic test markets.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating IMA

Add Stock to Watchlist

What the Community Thinks

Total Members

211 Outperforms
21 Underperforms
 

All-Stars

76 Outperforms
3 Underperforms
 

Wall Street

9 Outperforms
0 Underperforms
 

Members bullish on IMA are also bullish on:

Members bearish on IMA are also bearish on:

Ticker Tags

Value (1901), Mid Cap (610), Technical Instruments (62), Healthcare (711), Defensive (1457), Healthcare Equipment and Supplies (176)
Suggest a tag

Inverness Medical Innovations, Inc. At A Glance

Current Price: $41.17
Last Trade Time: 2/9/2010 4:05 PM
Open: $0.00
Previous Close: $41.50
Daily Range: $40.98 - $42.20
52-Week Range: $20.99 - $44.87
Volume: 603,106
Market Cap: $3.43B
P/E Ratio: 133.87
Compare Our Special Broker Offers!

Stock Trends

IMA VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Inverness Medical Innovations, Inc. (IMA)

Avatar knuckledragger83 (84.25) Submitted: 1/27/09 11:05 PM

Stock is so controversial but is a real company that has been forced to stop making acquisitions and focus on integration. CEO is pounding 25% EPS growth. Trades at less than 10x forward PE or 0.4x PEG. Great company in right market position. Now be warned, this has been favorite of short sellers bu...More

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

2

Inverness Medical Innovations, Inc. (IMA)

Avatar hleggett (62.10) Submitted: 2/26/08 4:15 PM

Adown to half former value, it's going lower. Management cannot explain why it's paying $900 million for a $475 million company, Matria. Yep, it's a stinker until the CEO can explain this deal. Obviously, the shareholders aren't buying the sorry guidance thus far ....

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 31 :   1 2 3 4 5 Next »

Show Pitch Replies

Recs

0

 (IMA)

Avatar mrbill6 (< 20) Submitted: 1/09/10 2:14 AM : Outperform Start Price: $42.97 IMA Score: 2.63

navallier:A, msn:9

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IMA)

Avatar carfang (51.39) Submitted: 8/26/09 2:22 PM : Outperform Start Price: $36.33 IMA Score: 8.82

Once they improve their debt - will be well positioned

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IMA)

Avatar 000127 (< 20) Submitted: 7/22/09 8:10 AM : Outperform Start Price: $32.55 IMA Score: 13.05

had some problems in ireland.....will rebound strong

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IMA)

Avatar onegreeneyes29 (< 20) Submitted: 1/28/09 4:08 PM : Underperform Start Price: $25.00 IMA Score: -37.99

A poor second place in Cardiovascular POC, with an inferior product that is being sold under cost to buy marketshare. I wouldn't put my money here when they are going against a powerhouse like Roche. They are losing marketshare in the small segments of the market--the only place they ever excelled. IMI is also bogged down by a lot of acquisition confusion and look at their debt.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (IMA)

Avatar knuckledragger83 (84.25) Submitted: 1/27/09 11:05 PM : Outperform Start Price: $25.00 IMA Score: 38.39

Stock is so controversial but is a real company that has been forced to stop making acquisitions and focus on integration. CEO is pounding 25% EPS growth. Trades at less than 10x forward PE or 0.4x PEG. Great company in right market position. Now be warned, this has been favorite of short sellers but hard to see that focus if earnings stay strong. Like a $40+ price by end of 2009.

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 31 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer < 20 09/25/09 Outperform 3W $37.37+10.17%+2.36%+7.81
TrackAvondale 87.18 03/24/09 Outperform NS $26.46+55.59%+32.76%+22.83
TrackLazardCapit < 20 10/14/08 Outperform NS $24.33+69.19%+5.06%+64.13
TrackCanaccord 86.15 08/07/08 Outperform NS $33.78+21.87%-13.67%+35.54
TrackRonBaron 59.71 09/30/07 Outperform NS $52.42-21.46%-26.38%+4.92 Toggle the visibility of 60-Second Pitch and replies
TrackSoros 82.58 09/30/07 Outperform NS $52.42-21.46%-26.38%+4.92 Toggle the visibility of 60-Second Pitch and replies
TrackStifel 96.44 06/06/07 Outperform NS $43.93-6.28%-25.87%+19.59
TrackCarisandCo 86.28 01/29/07 Outperform NS $38.85+5.97%-19.96%+25.93
TrackJefferies 82.08 09/01/06 Outperform NS $32.24+27.71%-12.84%+40.56

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD04 875ms